Chemical Component Summary | |
---|---|
Name | MANGANESE (II) ION |
Identifiers | manganese(+2) cation |
Formula | Mn |
Molecular Weight | 54.94 |
Type | NON-POLYMER |
Isomeric SMILES | [Mn++] |
InChI | InChI=1S/Mn/q+2 |
InChIKey | WAEMQWOKJMHJLA-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 2 |
Atom Count | 1 |
Chiral Atom Count | 0 |
Chiral Atoms | n/a |
Bond Count | 0 |
Aromatic Bond Count | 0 |
Leaving Atoms | n/a |
Drug Info: DrugBank
DrugBank ID | DB06757 Different stereochemistry |
---|---|
Name | Manganese |
Groups |
|
Description | Manganese is a transition metal with a molar mass of 54.94g/mol. Manganese is considered critical for human health, and plays important roles in development, metabolism, and the antioxidant system. That said, excessive manganese intake is associated with manganism, a neurodegenerative disorder that causes dopaminergic neuronal death and parkinsonian-like symptoms. |
Salts |
|
Brand Names |
|
Affected Organism | Humans and other mammals |
Indication | Indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. |
Route of administration |
|
Categories |
|
CAS number | 7439-96-5 |